Clinical Trial Update: Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2 [Phase 1]

View source ↗

Summary

Phase 1-2 trial assessing the efficacy of stem cell therapy in ambulatory and non-ambulatory children with Duchenne Muscular Dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: University of Gaziantep | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: UNKNOWN